Search for Clinical Trial Results
Anaplastic Large Cell Lymphoma - 340 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma Condition:
|
Withdrawn |
Study Name: Denileukine Diftitox for Relapsed ALCL Condition: Anaplastic Large-Cell Lymphoma Date: 2008-12-03 Interventions:
|
Completed |
Study Name: 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma Condition:
|
Recruiting |
Study Name: Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL Condition: ALK+ Anaplastic Large Cell Lymphoma Date: 2015-05-18 Interventions:
|
Recruiting |
Study Name: Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Condition:
|
Suspended |
Study Name: Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Condition:
|
Completed |
Study Name: Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma Condition: Lymphoma Date: 2011-06-02 Interventions:
|
Completed |
Study Name: Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Condition: Lymphoma Date: 2003-05-06 Interventions:
|
Active, not recruiting |
Study Name: Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma Condition: Lymphoma Date: 2006-04-19 Interventions:
|
Active, not recruiting |
Study Name: Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Condition: Lymphoma Date: 2000-11-06 Interventions:
|